Market Tracker

09/18 3:24am ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

8.16
Data as of Sep 17
 -0.16 / -1.92%
Today’s Change
7.44
Today|||52-Week Range
82.80
-26.49%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close8.32
Today’s open9.02
Day’s range8.05 - 9.02
Volume18,363
Average volume (3 months)24,465
Market cap$107.6M
Dividend yield--
Data as of 3:59pm ET, 09/17/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+88.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio2.6
Price/Sales1.73
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...+0.08+1.47%
MDGNMedgenics Inc-0.14-2.46%
CNATConatus Pharmaceutic...-0.02-0.30%
VICLVical Inc-0.01-0.84%
Data as of 4:01pm ET, 09/17/2014

Financials

Last reporting dateAugust 6, 2014
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts